• Number of patients with untreated newly diagnosed IBC participating in Registry [ Time Frame: 6 Years ] [ Designated as safety issue: No ]
  

IBC:

IBC is a rare but rapidly growing form of breast cancer. Currently, there are no known risk factors and biological features (such as in the genes) that researchers can use to help design better treatments for IBC.

Study Participation:

Participants in this study will be identified at the time of their first visit to MD Anderson, or have been treated for IBC and now are seeking further treatment in the IBC clinic at MD Anderson. If you agree to take part in this study, you will have the following tests/procedures performed.

• You will have additional blood (about 4 tablespoons) drawn for this study, during a routine blood draw.
• For patients who have never received treatment for IBC: You will have a core, breast tissue, and skin biopsy. If lymph nodes are noticed during the core biopsy, lymph nodes core biopsy or final needle aspiration will be done as well. To perform a core, breast tissue, and skin biopsy, an affected area of skin is numbed with anesthetic, and a small amount of skin tissue is removed with a small knife. This is a fresh sample collected for diagnosis and for the study.
• For patients who have received treatment for IBC: Your original biopsy specimen will be collected for diagnosis (if needed by your doctor) and for the study.
• You will have an interview. During this interview, you will be asked questions about your medical history as well as general background information. The interview will be conducted by the study chair or their designee in the examination room and after the meeting with the physician in a private setting. The interview will take about 30 minutes to complete. Language Assistance will be called if a participant is non-English speaking.
• Your clinical data will be collected from your medical record, including information about your blood and tumor tissue samples and information from the magnetic resonance imaging (MRI) and positron emission tomography/computed tomography (PET/CT) scans you may have had.
• Photos of both breasts will be taken if needed.

Length of Study:

Your participation in this study will be complete after your samples and data are collected.

Research Tissue Bank:

Before your blood and tissue samples and information can be used for research, the people doing the research must get specific approval from the Institutional Review Board (IRB) of MD Anderson. The IRB is a committee made up of doctors, researchers, and members of the community. The IRB is responsible for protecting the participants involved in research studies and making sure all research is done in a safe and ethical manner. All research done at MD Anderson, including research involving your samples and information from this bank, must first be approved by the IRB.

This is an investigational study. Up to 450 patients will take part in this study. Up to 300 will be enrolled at MD Anderson.